2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC748
Submitter : Dr. Bridget Bly Date & Time: 10/13/2005 08:10:17
Organization : Dr. Bridget Bly
Category : Individual Consumer
Issue Areas/Comments
I am outraged that the FDA has failed to follow the recommendation of its own advisory panel to release the "morning after pill" (Plan B) to consumers. It's blatant political nonsense, and it makes the FDA look like a pawn of politicians. Women need this drug, they have a right to it, and to withhold it violates a woman's right to choose.